Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Fletcher, CV' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 46 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kline, MW; Brundage, RC; Fletcher, CV; Schwarzwald, H; Calles, NR; Buss, NE; Snell, P; Delora, P; Eason, M; Jorga, K; Craig, C; Duff, F
      Combination therapy with saquinavir soft gelatin capsules in children withhuman immunodeficiency virus infection

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    2. Kakuda, TN; Page, LM; Anderson, PL; Henry, K; Schacker, TW; Rhame, FS; Acosta, EP; Brundage, RC; Fletcher, CV
      Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    3. Acosta, EP; Kakuda, TN; Brundage, RC; Anderson, PL; Fletcher, CV
      Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors

      CLINICAL INFECTIOUS DISEASES
    4. Haas, DW; Clough, LA; Johnson, BW; Harris, VL; Spearman, P; Wilkinson, GR; Fletcher, CV; Fiscus, S; Raffanti, S; Donlon, R; McKinsey, J; Nicotera, J; Schmidt, D; Shoup, RE; Kates, RE; Lloyd, RM; Larder, B
      Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    5. Anderson, PL; Noormohamed, SE; Henry, K; Brundage, RC; Balfour, HH; Fletcher, CV
      Semen and serum pharmacokinetics of zidovudine and zidovudine-glucuronide in men with HIV-1 infection

      PHARMACOTHERAPY
    6. Fletcher, CV; Acosta, EP; Cheng, HL; Haubrich, R; Fischl, M; Raasch, R; Mills, C; Hu, XJ; Katzenstein, D; Remmel, RP; Gulick, RM
      Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV-infected subjects: ACTG 884

      AIDS
    7. Anderson, PL; Brundage, RC; Bushman, L; Kakuda, TN; Remmel, RP; Fletcher, CV
      Indinavir plasma protein binding in HIV-1-infected adults

      AIDS
    8. Fletcher, CV; Kawle, SP; Kakuda, TN; Anderson, PL; Weller, D; Bushman, LR; Brundage, RC; Remmel, RP
      Zidovudine triphosphate and lamivudine triphosphate concentration-responserelationships in HIV-infected persons

      AIDS
    9. Leflore, S; Anderson, PL; Fletcher, CV
      A risk-benefit evaluation of aciclovir for the treatment and prophylaxis of herpes simplex virus infections

      DRUG SAFETY
    10. Fletcher, CV; Brundage, RC; Remmel, RP; Page, LM; Weller, D; Calles, NR; Simon, C; Kline, MW
      Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapy

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    11. Spector, SA; Hsia, K; Yong, FH; Cabral, S; Fenton, T; Fletcher, CV; McNamara, J; Mofenson, LM; Starr, SE
      Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected children

      JOURNAL OF INFECTIOUS DISEASES
    12. Shearer, WT; Israel, RJ; Starr, S; Fletcher, CV; Wara, D; Rathore, M; Church, J; DeVille, J; Fenton, T; Graham, B; Samson, P; Staprans, S; McNamara, J; Moye, J; Maddon, PJ; Olson, WC
      Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: Phase 1/2 study

      JOURNAL OF INFECTIOUS DISEASES
    13. Gulick, RM; Hu, XJ; Fiscus, SA; Fletcher, CV; Haubrich, R; Cheng, HL; Acosta, E; Lagakos, SW; Swanstrom, R; Freimuth, W; Snyder, S; Mills, C; Fischl, M; Pettinelli, C; Katzenstein, D
      Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group study 359

      JOURNAL OF INFECTIOUS DISEASES
    14. Jacobson, JM; Lowy, I; Fletcher, CV; O'Neill, TJ; Tran, DNH; Ketas, TJ; Trkola, A; Klotman, ME; Maddon, PJ; Olson, WC; Israel, RJ
      Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults

      JOURNAL OF INFECTIOUS DISEASES
    15. Stiehm, ER; Fletcher, CV; Mofenson, LM; Palumbo, PE; Kang, MH; Fenton, T; Sapan, CV; Meyer, WA; Shearer, WT; Hawkins, E; Fowler, MG; Bouquin, P; Purdue, L; Sloand, EM; Nemo, GJ; Wara, D; Bryson, YJ; Starr, SE; Petru, A; Burchett, S
      Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulinin HIV type 1-infected children (Pediatric AIDS Clinical Trials Group Protocol 273)

      JOURNAL OF INFECTIOUS DISEASES
    16. Remmel, RP; Kawle, SP; Weller, D; Fletcher, CV
      Simultaneous HPLC assay for quantification of indinavir, nelfinavir, ritonavir, and saquinavir in human plasma

      CLINICAL CHEMISTRY
    17. Fletcher, CV
      Pharmacologic considerations for therapeutic success with antiretroviral agents

      ANNALS OF PHARMACOTHERAPY
    18. Acosta, EP; Henry, K; Baken, L; Page, LM; Fletcher, CV
      Indinavir concentrations and antiviral effect

      PHARMACOTHERAPY
    19. Kakuda, TN; Brundage, RC; Anderson, PL; Fletcher, CV
      Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy

      AIDS
    20. Kline, MW; Blanchard, S; Fletcher, CV; Shenep, JL; McKinney, RE; Brundage, RC; Culnane, M; Van Dyke, RB; Dankner, WM; Kovacs, A; McDowell, JA; Hetherington, S
      A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection

      PEDIATRICS
    21. Starr, SE; Fletcher, CV; Spector, SA; Yong, FH; Fenton, T; Brundage, RC; Manion, D; Ruiz, NM; Gersten, M; Becker, M; McNamara, J; Mofenson, LM
      Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1

      NEW ENGLAND JOURNAL OF MEDICINE
    22. Kakuda, TN; Acosta, EP; Fletcher, CV
      Potential confusion with antiretroviral drugs

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    23. KLINE MW; FLETCHER CV; HARRIS AT; EVANS KD; BRUNDAGE RC; REMMEL RP; CALLES NR; KIRKPATRICK SB; SIMON C
      A PILOT-STUDY OF COMBINATION THERAPY WITH INDINAVIR, STAUVIDINE (D4T), AND DIDANOSINE (DDI) IN CHILDREN INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS

      The Journal of pediatrics
    24. FLETCHER CV; ACOSTA EP; HENRY K; PAGE LM; GROSS CR; KAWLE SP; REMMEL RP; ERICE A; BALFOUR HH
      CONCENTRATION-CONTROLLED ZIDOVUDINE THERAPY

      Clinical pharmacology and therapeutics
    25. ACOSTA EP; FLETCHER CV
      VALACYCLOVIR

      The Annals of pharmacotherapy
    26. ACOSTA EP; HENRY K; PAGE LM; ERICE A; BALFOUR HH; FLETCHER CV
      PHARMACOKINETICS AND SAFETY OF CONCENTRATION-CONTROLLED ORAL ZIDOVUDINE THERAPY

      Pharmacotherapy
    27. FLETCHER CV; GOODROAD BK; CUMMINS LM; HENRY K; BALFOUR HH; RHAME FS
      PHARMACOKINETICS OF HYPERIMMUNE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS IMMUNOGLOBULIN IN PERSONS WITH AIDS

      Antimicrobial agents and chemotherapy
    28. LAMBERT JS; MOFENSON LM; FLETCHER CV; MOYE J; STIEHM ER; MEYER WA; NEMO GJ; MATHIESON BJ; HIRSCH G; SAPAN CV; CUMMINS LM; JIMENEZ E; ONEILL E; KOVACS A; STEK A
      SAFETY AND PHARMACOKINETICS OF HYPERIMMUNE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) IMMUNOGLOBULIN ADMINISTERED TO HIV-INFECTED PREGNANT-WOMEN AND THEIR NEWBORNS

      The Journal of infectious diseases
    29. FLETCHER CV
      PHARMACOLOGICAL CONSIDERATIONS FOR ANTIVIRAL DRUG DEVELOPMENT

      The Annals of pharmacotherapy
    30. ACOSTA EP; PAGE LM; FLETCHER CV
      CLINICAL PHARMACOKINETICS OF ZIDOVUDINE - AN UPDATE

      Clinical pharmacokinetics
    31. FLETCHER CV; BALFOUR HH
      VARIABILITY IN ZIDOVUDINE SERUM CONCENTRATIONS

      Pharmacotherapy
    32. BALFOUR HH; FLETCHER CV; ERICE A; HENRY WK; ACOSTA EP; SMITH SA; HOLM MA; BOIVIN G; SHEPP DH; CRUMPACKER CS; EATON CA; MARTINMUNLEY SS
      EFFECT OF FOSCARNET ON QUANTITIES OF CYTOMEGALOVIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS IN BLOOD OF PERSONS WITH AIDS

      Antimicrobial agents and chemotherapy
    33. KLINE MW; FLETCHER CV; FEDERICI ME; HARRIS AT; EVANS KD; RUTKIEWICZ VL; SHEARER WT; DUNKLE LM
      COMBINATION THERAPY WITH STAVUDINE AND DIDANOSINE IN CHILDREN WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - PHARMACOKINETIC PROPERTIES, SAFETY, AND IMMUNOLOGICAL AND VIROLOGICAL EFFECTS

      Pediatrics
    34. KLINE MW; FLETCHER CV; FEDERICI ME; HARRIS AT; EVANS KD; RUTKIEWICZ VL; SHEARER WT; DUNKLE LM
      COMBINATION THERAPY WITH STAVUDINE (D4T) AND DIDANOSINE (DDI) IN CHILDREN WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION

      Pediatric research
    35. ACOSTA EP; SCHWEBKE K; HENRY K; FLETCHER CV
      DISPOSITION OF ZIDOVUDINE IN OBESE PREGNANT-WOMEN WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION

      The Journal of infectious diseases
    36. BRICELAND LL; CLEARY JD; FLETCHER CV; HEALY DP; PELOQUIN CA
      RECENT ADVANCES - ANTIINFECTIVES

      The Annals of pharmacotherapy
    37. SCHWEBKE K; FLETCHER CV; ACOSTA EP; HENRY K
      PENTAMIDINE CONCENTRATIONS IN A MOTHER WITH AIDS AND IN HER NEONATE

      Clinical infectious diseases
    38. ACOSTA EP; FLETCHER CV
      ANTIRETROVIRAL DRUG-INTERACTIONS

      International journal of antimicrobial agents
    39. FLETCHER CV; HENRY WK; NOORMOHAMED SE; RHAME FS; BALFOUR HH
      THE EFFECT OF CIMETIDINE AND RANITIDINE ADMINISTRATION WITH ZIDOVUDINE

      Pharmacotherapy
    40. NOORMOHAMED SE; HENRY WK; RHAME FS; BALFOUR HH; FLETCHER CV
      STRATEGIES FOR CONTROL OF ZIDOVUDINE CONCENTRATIONS IN SERUM

      Antimicrobial agents and chemotherapy
    41. FLETCHER CV; ACOSTA EP; STRYKOWSKI JM
      GENDER DIFFERENCES IN HUMAN PHARMACOKINETICS AND PHARMACODYNAMICS

      Journal of adolescent health
    42. KOEHNTOP DE; NOORMOHAMED SE; FLETCHER CV
      EFFECTS OF LONG-TERM DRUGS ON ALFENTANIL CLEARANCE IN PATIENTS UNDERGOING RENAL-TRANSPLANTATION

      Pharmacotherapy
    43. FLETCHER CV; COLLIER AC; RHAME FS; BENNETT D; PARA MF; BEATTY CC; JONES CE; BALFOUR HH
      FOSCARNET FOR SUPPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION

      Antimicrobial agents and chemotherapy
    44. ACOSTA EP; FLETCHER CV
      AGENTS FOR TREATING HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      American journal of hospital pharmacy
    45. FLETCHER CV
      CURRENT PERSPECTIVES ON ANTIRETROVIRAL THERAPY

      Pharmacotherapy
    46. FLETCHER CV; ACOSTA EP
      ADVANCES IN PHARMACOTHERAPY - TREATMENT OF HIV-INFECTION

      Journal of clinical pharmacy and therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/06/20 alle ore 06:17:41